(Q28283074)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17219030%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

review article

1 reference

title

News on the genetics, epidemiology, medical care and translational research of Schwannomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17219030%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17219030%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Gareth Evans

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17219030%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

C O Hanemann

series ordinal

1

0 references

D G Evans

series ordinal

2

0 references

language of work or name

English

0 references

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17219030%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17219030%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

253

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17219030%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17219030%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

1533-1541

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17219030%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00415-006-0347-0

24 December 2019

exact match

0 references

cites work

Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling

1 reference

12 December 2020

A clinical study of type 2 neurofibromatosis

1 reference

12 December 2020

Exploring the "two-hit hypothesis" in NF2: tests of two-hit and three-hit models of vestibular schwannoma development.

1 reference

12 December 2020

Incidence of vestibular schwannomas

1 reference

12 December 2020

Neurofibromatosis 2, radiosurgery and malignant nervous system tumours

1 reference

12 December 2020

Merlin, the Product of the Nf2 Tumor Suppressor Gene, Is an Inhibitor of the p21-Activated Kinase, Pak1

1 reference

12 December 2020

Treatment of schwannomas with an oncolytic recombinant herpes simplex virus in murine models of neurofibromatosis type 2.

1 reference

12 December 2020

Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2.

1 reference

12 December 2020

Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation

1 reference

12 December 2020

Spinal tumors in patients with neurofibromatosis type 2: MR imaging study of frequency, multiplicity, and variety

1 reference

12 December 2020

Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.

1 reference

12 December 2020

Fludeoxyglucose F 18 positron emission tomography and computed tomography of a giant retroperitoneal schwannoma occurring in a patient with neurofibromatosis type 2.

1 reference

12 December 2020

Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas

1 reference

12 December 2020

Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution.

1 reference

12 December 2020

Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study

1 reference

12 December 2020

Surgery of spinal nerve sheath tumors with special reference to neurofibromatosis

1 reference

12 December 2020

[Tumors of the central nervous system in biopsy and autopsy material. 7th communication: neurinomas and neurofibromatoses with CNS involvement]

1 reference

12 December 2020

Merlin suppresses the SRE-dependent transcription by inhibiting the activation of Ras-ERK pathway

1 reference

12 December 2020

Rearrangements of the intermediate filament GFAP in primary human schwannoma cells

1 reference

12 December 2020

Detection of spontaneous schwannomas by MRI in a transgenic murine model of neurofibromatosis type 2.

1 reference

12 December 2020

Signal therapy of NF1-deficient tumor xenograft in mice by the anti-PAK1 drug FK228.

1 reference

12 December 2020

Vestibular (acoustic) schwannomas: histologic features in neurofibromatosis 2 and in unilateral cases

1 reference

12 December 2020

A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity

1 reference

12 December 2020

Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought

1 reference

12 December 2020

Vestibular schwannoma growth rates in neurofibromatosis type 2 natural history consortium subjects

1 reference

12 December 2020

The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.

1 reference

12 December 2020

Hearing changes after diagnosis in neurofibromatosis type 2.

1 reference

12 December 2020

Predictors of the risk of mortality in neurofibromatosis 2

1 reference

12 December 2020

Management of 1000 vestibular schwannomas (acoustic neuromas): hearing function in 1000 tumor resections

1 reference

12 December 2020

Schwannoma of the extremities: the role of PET in preoperative planning

1 reference

12 December 2020

Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease

1 reference

12 December 2020

Management of 1000 vestibular schwannomas (acoustic neuromas): the facial nerve--preservation and restitution of function.

1 reference

12 December 2020

PET-methionine of skull base neuromas and meningiomas.

1 reference

12 December 2020

Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities.

1 reference

12 December 2020

Upregulation of the Rac1/JNK signaling pathway in primary human schwannoma cells

1 reference

12 December 2020

Neurofibromatosis type 2

1 reference

12 December 2020

A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitor

1 reference

12 December 2020

Benign spinal nerve sheath tumors: their occurrence sporadically and in neurofibromatosis types 1 and 2

1 reference

12 December 2020

Surgery of spinal nerve schwannoma. Risk of neurological deficit after resection of involved root

1 reference

12 December 2020

Isolation and characterization of Schwann cells from neurofibromatosis type 2 patients

1 reference

12 December 2020

Enhanced proliferation and potassium conductance of Schwann cells isolated from NF2 schwannomas can be reduced by quinidine

1 reference

12 December 2020

A case of multiple cutaneous schwannomas; schwannomatosis or neurofibromatosis type 2?

1 reference

12 December 2020

Size and growth rate of sporadic vestibular schwannoma: predictive value of information available at presentation

1 reference

12 December 2020

Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2.

1 reference

12 December 2020

Diagnostic criteria for schwannomatosis

1 reference

12 December 2020

Spinal and cutaneous schwannomatosis is a variant form of type 2 neurofibromatosis: a clinical and molecular study

1 reference

12 December 2020

Clinical experience with gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis

1 reference

12 December 2020

Increasing the specificity of diagnostic criteria for schwannomatosis

1 reference

12 December 2020

Spinal tumors in neurofibromatosis type 2. Is emerging knowledge of genotype predictive of natural history?

1 reference

12 December 2020

VEGF and VEGF receptor-1 concentration in vestibular schwannoma homogenates correlates to tumor growth rate.

1 reference

12 December 2020

Intramedullary and spinal canal tumors in patients with neurofibromatosis 2: MR imaging findings and correlation with genotype

1 reference

12 December 2020

Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas

1 reference

12 December 2020

HRS inhibits EGF receptor signaling in the RT4 rat schwannoma cell line.

1 reference

12 December 2020

Positron emission tomographic imaging of acoustic neuromas

1 reference

12 December 2020

Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors

1 reference

12 December 2020

Pathological adhesion of primary human schwannoma cells is dependent on altered expression of integrins.

1 reference

12 December 2020

Issues and progress with protein kinase inhibitors for cancer treatment

1 reference

12 December 2020

Management of the patient and family with neurofibromatosis 2: a consensus conference statement

1 reference

12 December 2020

Acoustic neuroma. Assessment and management

1 reference

12 December 2020

Somatic mosaicism in neurofibromatosis 2: prevalence and risk of disease transmission to offspring

1 reference

12 December 2020

Transduction of wild-type merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosis

1 reference

12 December 2020

Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study

1 reference

12 December 2020

Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery

1 reference

12 December 2020